论文部分内容阅读
目的:针对小儿肺炎,讨论实施雾化吸入或静滴盐酸氨溴索的辅助治疗效果,为日后的临床治疗提供参考与指导。方法:选择我院于2013年2月—2015年3月收治的小儿肺炎患儿120例为研究对象,应用随机数表法,将120例患儿划分为观察组与对照组。针对对照组患儿,应用常规治疗;针对观察组患儿,在常规治疗基础上,实施雾化吸入或静滴盐酸氨溴索辅助治疗,对比两组患儿的临床疗效。结果:经过临床治疗,观察组患儿治疗总有效率为95.8%,对照组患儿治疗总有效率为79.2%,两组患儿比较差异显著,临床有统计学意义,P<0.05。结论:针对小儿肺炎,单纯实施常规治疗,难以达到理想效果。配合实施雾化吸入或静滴盐酸氨溴索辅助治疗后,能够进一步减轻患儿的症状、体征(发热、咳嗽及肺部罗音),缩短病程,无明显不良反应发生。建议在今后的临床治疗中,将雾化吸入或静滴盐酸氨溴索辅助治疗推广应用。
Objective: To investigate the effect of adjuvant therapy with ambroxol hydrochloride or ambroxol hydrochloride in children with pneumonia and provide reference and guidance for future clinical treatment. Methods: A total of 120 children with pneumonia in our hospital from February 2013 to March 2015 were selected as study subjects. 120 children were divided into observation group and control group by random number table method. For the control group of children, the application of conventional treatment; for the observation group of children, on the basis of routine treatment, the implementation of atomization inhalation or infusion of ambroxol hydrochloride adjuvant therapy, compared the clinical efficacy of two groups of children. Results: After clinical treatment, the total effective rate was 95.8% in the observation group and 79.2% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: For children with pneumonia, simple implementation of conventional treatment, it is difficult to achieve the desired effect. With the implementation of atomization inhalation or infusion of ambroxol hydrochloride adjuvant therapy, to further reduce the children’s symptoms and signs (fever, cough and lung rales), shorten the course of the disease, no obvious adverse reactions. Proposed in the future clinical treatment, inhalation or intravenous ambroxol hydrochloride adjuvant therapy to promote the use of.